BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 24737136)

  • 1. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).
    Watanabe T; Kawasaki M; Tanaka R; Ono K; Kako N; Saeki M; Onishi N; Nagaya M; Sato N; Miwa H; Arai M; Noda T; Watanabe S; Minatoguchi S
    Cardiovasc Ultrasound; 2015 Apr; 13():17. PubMed ID: 25889304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.
    Skagen K; Johnsrud K; Evensen K; Scott H; Krohg-Sørensen K; Reier-Nilsen F; Revheim ME; Fjeld JG; Skjelland M; Russell D
    Int J Stroke; 2015 Jul; 10(5):730-6. PubMed ID: 25588553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.
    Bucerius J; Duivenvoorden R; Mani V; Moncrieff C; Rudd JH; Calcagno C; Machac J; Fuster V; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1195-205. PubMed ID: 22093271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
    Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
    J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of F-18 FDG and ultrasound analysis of carotid plaque.
    Choi YS; Youn HJ; Chung WB; Hwang HJ; Lee DH; Park CS; Lee JB; Kim PJ; Chung WS; Lee MY; Seung KB; Chung YA
    J Nucl Cardiol; 2011 Apr; 18(2):267-72. PubMed ID: 21279492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study.
    Toutouzas K; Koutagiar I; Benetos G; Aggeli C; Georgakopoulos A; Athanasiadis E; Pianou N; Trachanellis S; Patelis N; Agrogiannis G; Kafouris P; Filis K; Bessias N; Klonaris C; Spyrou G; Tsiamis E; Siores E; Patsouris E; Cokkinos D; Tousoulis D; Anagnostopoulos CD
    Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1236-1244. PubMed ID: 28011672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Kim TN; Kim S; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):142-8. PubMed ID: 20061516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18FDG PET and ultrasound echolucency in carotid artery plaques.
    Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.